The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - BioNTech SE
Leadership - BioNTech SE
Stock and Other Ownership Interests - BioNTech SE
Research Funding - BioNTech SE (Inst)
Patents, Royalties, Other Intellectual Property - BioNTech SE
Other Relationship - Tron (I)
A phase 2 multicenter, open-label, randomized, controlled trial in patients with stage II/III colorectal cancer who are ctDNA positive following resection to compare efficacy of autogene cevumeran versus watchful waiting.
 
Scott Kopetz
Stock and Other Ownership Interests - Frontier Medicines; Iylon; Lutris; MolecularMatch
Consulting or Advisory Role - Abbvie; Amal Therapeutics; AstraZeneca/MedImmune; Bayer Health; Bicara Therapeutics; Boehringer Ingelheim; Boston Biomedical; Carina Biotech; Daiichi Sankyo; EMD Serono; EMD Serono; Endeavor BioMedicines; Flame Biosciences; Frontier Medicines; Genentech; Genomic Health; Gilead Sciences; GlaxoSmithKline; HalioDx; Holy Stone Healthcare; Inivata; Ipsen; Iylon; Jacobio; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Lutris; Merck; Mirati Therapeutics; Natera; Novartis; Numab; Pfizer; Pierre Fabre; Redx Pharma; Repare Therapeutics; Replimune; Servier; Taiho Pharmaceutical; Xilis
Research Funding - Amgen; Array BioPharma; Biocartis; Daiichi Sankyo; EMD Serono; Genentech/Roche; Guardant Health; Lilly; MedImmune; Novartis; Sanofi
 
Van K. Morris
Consulting or Advisory Role - Axiom Healthcare Strategies; Bicara Therapeutics; BioMedical Insights; Boehringer Ingelheim; Incyte; SERVIER
Research Funding - Bicara Therapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Immatics; Pfizer (Inst)
 
Vicente Alonso-Orduña
Consulting or Advisory Role - Amgen; Ipsen; Merck Serono; Novartis; Roche; Servier
 
Pilar Garcia-Alfonso
Consulting or Advisory Role - Amgen; Merck Serono; Pierre Fabre; SERVIER
Speakers' Bureau - Amgen; Merck Serono; Pierre Fabre; Sanofi; SERVIER
 
Margarita Reboredo
No Relationships to Disclose
 
Ana Fernandez Montes
Consulting or Advisory Role - Amgen; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Celgene; Lilly; Lilly; Roche; Sanofi; Seagen; SERVIER
 
Joan Maurel
Consulting or Advisory Role - AstraZeneca; Pierre Fabre; Sanofi; Servier; Shire; Sirtex Medical
Research Funding - Amgen; Biocartis; Biocartis; Incyte; Merck Serono; NanoString Technologies; Roche
Travel, Accommodations, Expenses - Amgen
Other Relationship - Advance Medical/Teladoc Health; AstraZeneca; Bayer; Cancer Expert Now; Fundación Clínica Universitaria; Pierre Fabre; Roche; Sanofi Pasteur; SERVIER; Shire; Sirtex Medical
 
David Paez
Honoraria - Amgen; Novartis; Sanofi
Consulting or Advisory Role - Amgen; Ipsen; SERVIER
Research Funding - Merck
Travel, Accommodations, Expenses - Amgen; Ipsen; Lilly; Merck; Roche; Sanofi; SERVIER
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Roche
 
Thomas Höhler
Stock and Other Ownership Interests - BioNTech; BMJ; Roche
Honoraria - Amgen; Merck KGaA
Consulting or Advisory Role - Amgen; Merck KGaA
Travel, Accommodations, Expenses - Sanofi
 
Javier Carrasco
Research Funding - AstraZeneca; Roche
Travel, Accommodations, Expenses - Roche
 
Barbara Marie Galligan
No Relationships to Disclose
 
Luisa Manning
Employment - BioNTech SE; Gradalis
 
Liane Preußner
Employment - BioNTech
Stock and Other Ownership Interests - biontech
 
Özlem Tureci
No Relationships to Disclose
 
Ugur Sahin
Employment - BioNTech SE
Leadership - BioNTech SE
Stock and Other Ownership Interests - BioNTech SE
Research Funding - BioNTech SE
Patents, Royalties, Other Intellectual Property - BioNTech SE; Tron
Other Relationship - Tron Translational Oncology Mainz (Inst)